|
| (3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid Basic information |
Product Name: | (3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid | Synonyms: | (3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid;(3R,5R,E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid;(E,3R,5R)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid;6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, (3R,5R,6E)-;(3R,5R,6E)-Pitavastatin;Monocalcium bis[(3R,5R,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate];*Lercanidipine Impurity 53;Pitavastatin (3R,5R)-Isomer | CAS: | 769908-13-6 | MF: | C25H24FNO4 | MW: | 421.46 | EINECS: | | Product Categories: | | Mol File: | 769908-13-6.mol | |
| (3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid Chemical Properties |
density | 1.352 | storage temp. | 2-8°C |
| (3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid Usage And Synthesis |
Uses | (3R,5R,6E)-Pitavastatin is the isomer of Pitavastatin (CAS# 147511-69-1), which has the potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2) |
| (3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid Preparation Products And Raw materials |
|